Showing posts with label Diagnostic. Show all posts
Showing posts with label Diagnostic. Show all posts

Friday, 13 March 2020

Pressure Monitoring Market | Analysis of Worldwide Industry Trends and Opportunities

According to research report "Pressure Monitoring Market By by Application (Respiratory, Glaucoma, Dialysis), Product (Device (Blood Pressure, Intracranial Pressure, Intraocular Pressure), Accessory), Procedure (Invasive), End User (Hospital, ASC, Diagnostic) - Global Forecast to 2020", provides a complete summary of the major drivers, restraints, challenges, opportunities, current market trends, and various strategies influencing the pressure monitoring market along with estimates and forecasts of the revenue and market share analysis.

Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=196787732



Pressure monitoring plays an important role in detecting the health problems of a patient. The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma.

Increase in the prevalence of the above mentioned diseases and growing aging population have increased the need for pressure monitoring and control in the market.

The major factors responsible for the growth of the pressure monitoring are the rising prevalence of chronic and acute diseases, growth of aging population, new product launches, increase in the lifestyle related diseases, and technological advancements.

Due to these factors, the demand for pressure monitoring is increasing. On the other hand, lack of trained professionals, short shelf life of the device, accuracy of devices has may restrain the growth of the market.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196787732

Geographically, the market is dominated by North America, followed by Europe. North America is expected to account for the largest share of the global market in 2015, with Asia having the highest growth rate during the forecast period.

Key players in the pressure monitoring market include Philips Healthcare (The Netherlands), GE Healthcare (U.K.), Welch Allyn, Inc. (U.S.), Medtronic (U.S.), and Drägerwerk AG & Co. KGaA (Germany).

Request for special pricing on bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=196787732

Monday, 9 December 2019

What is major factor of Glycomics / Glycobiology Market ?

According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

Glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

The following are the major objectives of the study :

1. To define, describe, and forecast the global glycobiology market on the basis of product, application, end user, and region
2. To provide detailed information regarding the major factors influencing the growth of the glycobiology market (drivers, restraints, opportunities, and industry-specific challenges)
3. To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall Glycobiology market
4. To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders
5. To forecast the Glycobiology market size of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World
6. To strategically profile the key players and comprehensively analyze their market shares and core competencies2
7. To track and analyze the competitive developments such as new product launches, agreements, collaborations, acquisitions, expansion and agreements in the glycomics market

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Key Players and Strategies Adopted by Them:

The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Oncology :
Glycomics plays a crucial role in analyzing the molecular mechanism of various types of cancers. Glycomics also plays an important role in identifying new biomarkers for cancers. Biomarkers are used as key diagnostic targets for various types of cancers. They can also be used for devising novel and personalized therapies for cancer patients. Owing to its ability to differentiate between protein sub-types based on the molecular structure of their glycan patterns, glycomics has emerged as an important research tool for the discovery and validation of protein-based cancer biomarkers.